11. March 2014 20:53
Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.
Myriad's shares fell 12 percent before the bell on Tuesday.
Myriad's problems started last June when the U.S. Supreme Court ruled that the company could not patent naturally occurring human genes, curbing the company's monopoly over a type of gene-based cancer tes... [More]
10. March 2014 07:35
Tell Your Senator to Pass the Forensic Science and Standards Act of 2013!
Unvalidated or improper forensic science has contributed to 49% of the 312 cases later overturned by DNA evidence. The Senate Commerce, Science and Transportation Committee is considering critical legislation that would help ensure that forensic disciplines are based on strong scientific research and governed by consistent and meaningful standards. The committee is scheduled to vote o... [More]
6. March 2014 18:19
A plan to require people facing trial for certain crimes to submit DNA samples to law enforcement has been rejected by the Oklahoma House, despite an emotional plea from the bill's author.
On Wednesday, the House voted 51-35 against the bill by Stillwater Republican Rep. Lee Denney who says the measure would help solve cases and would only target people charged with particularly heinous crimes.
But lawmakers raised concerns, including what happens to DNA profiles in cases... [More]
5. March 2014 23:22
The Council for Responsible Genetics believes that everyone should know what they're eating. Join us in supporting mandatory GMO labeling in Massachusetts by calling your legislators before the March 19th deadline! They need to hear from you. Visit www.marighttoknow.org for more information.
You think you should know what you're feeding your family? We do too! Massachusetts is considering mandatory GMO labeling legislation, but unless they hear from YOU before... [More]
4. March 2014 01:01
Genetic testing has grown to be a business big enough in China to warrant the government’s intervention. Early in February, the government quietly put the brakes on the provision of genetic tests to customers by domestic hospitals and a variety of medical and health institutions.
If the ban persists it could blunt the ambitions of Shenzhen-based BGI, which has the world’s largest gene-sequencing capacity, and its various competitors, including Beijing-based Berry Genomics,... [More]
4. March 2014 00:35
A large new study led by Boston researchers shows that a simple blood test is more accurate than the standard methods to screen for chromosomal abnormalities such as Down syndrome in a fetus, paving the way for a new generation of prenatal genetic tests to be offered to all pregnant women.
The research published Wednesday is the first US study to compare these new genetic tests with current screening tools in large numbers of low-risk pregnant women. It found the new tests produced far fewer ... [More]
28. February 2014 22:32
Today it is easy for long-forgotten photos or personal information to live online indefinitely. But what if the most personal data about you – your genetic makeup – lived online? An individual's genome contains a vast amount of information about inherited diseases and physical traits, all stored in strands of DNA. The consequences of being able to search, cross-reference, and analyze this information are profound, experts say.
Hundreds of thousands of people have already had ... [More]
27. February 2014 20:57
A former member of the editorial board of Food and Chemical Toxicology, the journal that published and then retracted the Séralini study on GM maize and Roundup, has written a letter to the editor of the journal condemning the retraction.He writes, "Your decision which can be interpreted as a will to eliminate scientific information that does not help supporting industrial interests is, in my view, unacceptable."Meanwhile 129 scientists have signed a statement opposing the retractio... [More]
26. February 2014 19:47
The Food and Drug Administration is weighing a fertility procedure that involves combining the genetic material of three people to make a baby free of certain defects, a therapy that critics say is an ethical minefield and could lead to the creation of designer babies.
The agency has asked a panel of experts to summarize current science to determine whether the approach — which has been performed successfully in monkeys by researchers in Oregon and in people more than a decade ago &mdas... [More]
26. February 2014 19:43
Should doctors be allowed to tinker with genes to produce a healthy baby?
That's the question a Food and Drug Administration panel will consider this week when it holds hearings on whether to allow a controversial fertility technique to be tested on women with mitochondrial disease.
The field's leading U.S. researcher, Shoukhrat Mitalipov, will be on hand Tuesday to explain and defend his work.
The FDA meeting was prompted by Mitalipov's research at Oregon Health & Science University in... [More]